- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.11. | MBX Biosciences completes phase 1 trial of diabetes drug | 3 | Investing.com | ||
| 18.11. | MBX Biosciences, Inc.: MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia | 90 | GlobeNewswire (Europe) | CARMEL, Ind., Nov. 18, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide... ► Artikel lesen | |
| 07.11. | MBX Biosciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | MBX Biosciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10. | MBX Biosciences (NYSE:MBX) Sets New 52-Week Low - Time to Sell? | 1 | MarketBeat | ||
| 08.10. | MBX Bio drops despite bullish views on Street | 1 | Seeking Alpha | ||
| 08.10. | MBX Biosciences earns Buy rating at three investment firms | 2 | Investing.com | ||
| 08.10. | MBX Biosciences outlook solid with JPMorgan's overweight rating, eyes key catalysts in next 12 months | 3 | Investing.com | ||
| MBX BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 08.10. | Jefferies sieht Aufwärtspotenzial bei MBX Biosciences-Aktie und hebt Fortschritte der PEP-Plattform hervor | 2 | Investing.com Deutsch | ||
| 08.10. | Guggenheim bullish on MBX Biosciences stock, driven by MBX 2109 potential | 1 | Investing.com | ||
| 08.10. | Jefferies sees upside in MBX Biosciences stock, highlights PEP platform advancements | 2 | Investing.com | ||
| 08.10. | Stifel sieht Wachstumspotenzial in MBX-Aktie, betont innovative PEP-Plattform | 6 | Investing.com Deutsch | ||
| 30.09. | MBX Biosciences, Inc.: MBX Biosciences Presents MBX 2109 Phase 2 Avail Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting | 3 | GlobeNewswire (USA) | ||
| 18.09. | Hedge Fund and Insider Trading News: John Paulson, Steve Cohen, Ray Dalio, Warren Buffett, Dmitry Balyasny, Anthony Scaramucci, Tidan Fund, Irenic Capital Management, MBX Biosciences Inc (MBX), Coinbase Global Inc (COIN), and More | 21 | Insider Monkey | ||
| 18.09. | Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir | 22 | Investing.com | ||
| 18.09. | OrbiMed executives purchase $12 million of MBX Biosciences stock | 1 | Investing.com | ||
| 18.09. | MBX Biosciences insiders purchase $10 million in stock | 2 | Investing.com | ||
| 18.09. | MBX Biosciences director buys $8 million in company stock | 1 | Investing.com | ||
| 18.09. | MBX Biosciences insider buys $8 million in company stock | 1 | Investing.com | ||
| 18.09. | MBX Biosciences insider purchases $8 million in company stock | 1 | Investing.com |
Seite:
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
MBX BIOSCIENCES INC gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 21,420 Euro und damit -0,65 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MBX BIOSCIENCES INC finden Sie auf Wallstreet Online.
